Ipswich Investment Management Co., Inc. Regenxbio Inc. Transaction History

Ipswich Investment Management Co., Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 11, 2019	SELL	$42.0 - $59.29 $1.22 Million - $1.73 Million	-29,132 Closed	0 $0
Q1 2019 Apr 12, 2019	SELL	$40.82 - $62.45 $23,267 - $35,596	-570 Reduced 1.92%	29,132 $1.67 Million
Q4 2018 Jan 15, 2019	SELL	$39.11 - $75.15 $8,995 - $17,284	-230 Reduced 0.77%	29,702 $1.25 Million
Q3 2018 Oct 09, 2018	SELL	$65.0 - $82.15 $87,035 - $109,998	-1,339 Reduced 4.28%	29,932 $2.26 Million
Q2 2018 Jul 18, 2018	BUY	$27.2 - $74.35 $255,299 - $697,849	9,386 Added 42.89%	31,271 $2.24 Million
Q1 2018 Apr 12, 2018	BUY	$24.05 - $37.5 $120 - $187	5 Added 0.02%	21,885 $653,000
Q4 2017 Jan 16, 2018	BUY	$26.0 - $34.6 $568,880 - $757,048	21,880	21,880 $728,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $313M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Ipswich Investment Management Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Ipswich Investment Management Co., Inc. with notifications on news.